Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
CVS Health is a healthcare plans business based in the US. CVS Health shares (CVS) are listed on the NYSE and all prices are listed in US Dollars. CVS Health employs 216,000 staff and has a trailing 12-month revenue of around $314.3 billion.
Finder Award
SoFi Invest
Robinhood
tastyworks
| Latest market close | $87.05 |
|---|---|
| 52-week range | $84.82 - $108.63 |
| 50-day moving average | $95.36 |
| 200-day moving average | $96.94 |
| Wall St. target price | $116.26 |
| PE ratio | 36.1814 |
| Dividend yield | $2.15 (2.81%) |
| Earnings per share (TTM) | $2.37 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $87.05 from 2023-01-30
| 1 week (2023-01-25) | 1.52% |
|---|---|
| 1 month (2022-12-30) | -6.59% |
| 3 months (2022-11-01) | -8.00% |
| 6 months (2022-08-01) | -9.34% |
| 1 year (2022-02-01) | -18.09% |
|---|---|
| 2 years (2021-02-01) | 21.82% |
| 3 years (2020-01-31) | 28.35% |
| 5 years (2018-02-01) | 10.48% |
Valuing CVS Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CVS Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CVS Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 36x. In other words, CVS Health shares trade at around 36x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
CVS Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3591. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CVS Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CVS Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $19.1 billion.
The EBITDA is a measure of a CVS Health's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $314.3 billion |
|---|---|
| Operating margin TTM | 4.7% |
| Gross profit TTM | $50.8 billion |
| Return on assets TTM | 3.97% |
| Return on equity TTM | 4.34% |
| Profit margin | 1% |
| Book value | $53.75 |
| Market capitalisation | $112.7 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CVS Health.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 18.73
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CVS Health's overall score of 18.73 (as at 12/31/2018) is excellent – landing it in it in the 19th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like CVS Health is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 1.92/100
Social score: 9.06/100
Governance score: 2.75/100
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. CVS Health scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that CVS Health hasn't always managed to keep its nose clean.
CVS Health Corp was last rated for ESG on: 2019-01-01.
| Total ESG score | 18.73 |
|---|---|
| Total ESG percentile | 18.84 |
| Environmental score | 1.92 |
| Social score | 9.06 |
| Governance score | 2.75 |
| Level of controversy | 3 |
Dividend payout ratio: 25.95% of net profits
Recently CVS Health has paid out, on average, around 25.95% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.81% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CVS Health shareholders could enjoy a 2.81% return on their shares, in the form of dividend payments. In CVS Health's case, that would currently equate to about $2.15 per share.
While CVS Health's payout ratio might seem fairly standard, it's worth remembering that CVS Health may be investing much of the rest of its net profits in future growth.
CVS Health's most recent dividend payout was on 31 January 2023. The latest dividend was paid out to all shareholders who bought their shares by 18 January 2023 (the "ex-dividend date").
CVS Health's shares were split on a 2:1 basis on 6 June 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your CVS Health shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for CVS Health shares which in turn could have impacted CVS Health's share price.
Over the last 12 months, CVS Health's shares have ranged in value from as little as $84.82 up to $108.626. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CVS Health's is 0.6829. This would suggest that CVS Health's shares are less volatile than average (for this exchange).
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.
